English
繁體中文
Melayu
Nederlands
日本語
Italiano
Deutsch
Português
Español
Pусский
Français
العربية
简体中文
Bahasa indonesia
Polski

NEWS DETAIL
Home » News » News » Bioteke PR2026-RP06: Innovative 29-target Detection Solution for Multiple Respiratory Pathogens

Bioteke PR2026-RP06: Innovative 29-target Detection Solution for Multiple Respiratory Pathogens

Publish Time: 2025-03-21     Origin: Bioteke


Bioteke PR2026-RP06: Innovative Respiratory Multiple Pathogen Detection Solution



    As respiratory infections continue to evolve around the world, medical laboratories, disease control centers, hospitals and other institutions have an increasing demand for efficient and accurate pathogen detection. Bioteke PR2026-RP06 Respiratory Multiple Pathogen Nucleic Acid Detection Kit(Fluorescence PCR method), with its leading RT-qPCR technology and fully premixed freeze-dried system, provides an innovative solution for in vitro qualitative diagnosis of 29 common pathogens in upper and lower respiratory tract samples. 

    This article will deeply analyze the core technology, application advantages and key role of the kit in international respiratory infection diagnosis.


Overview

    Bioteke PR2026-RP06 is designed for common clinical respiratory infections. It achieves highly sensitive and specific nucleic acid detection through specific primers and fluorescent probes for 29 pathogens. 

    The product is based on RT-qPCR and fluorescent probe technology to ensure that various pathogens can be accurately distinguished even in mixed samples, helping medical institutions to achieve rapid and comprehensive etiology diagnosis.


Highlights

1. Multiple detection platforms

(1). Covering 29 common pathogens 

    Comprehensive detection of the causes of upper and lower respiratory tract infections to meet diverse clinical needs.


(2). Specific primer and probe design

    Ensure accurate identification of various pathogens in complex samples and reduce the risk of misjudgment.


2. RT-qPCR and fluorescent probe technology

(1). Real-time quantitative detection

    Through reverse transcription and real-time fluorescence monitoring, efficient amplification of pathogen nucleic acid is achieved, with a short detection cycle and high reaction sensitivity.


(2). Precise diagnosis

    The technical advantages ensure that low-copy pathogens can also be detected in a timely manner, reducing the probability of false positives and false negatives.


3. Fully premixed freeze-dried system

(1). Integrated premixed reagents

    All reverse transcriptases, amplification enzymes, reaction buffers, primers and probes are premixed and freeze-dried in PCR tubes. The operation is simple and convenient. You only need to add the reconstitution solution and sample nucleic acid to test.


(2). Long-term stability and convenient transportation

    Freeze-drying technology ensures the stability of reagents in different environments. It is suitable for various laboratories and areas with limited resources, and helps international standardized testing processes.


Application Advantages

Rapid response and high-throughput detection

Improve diagnostic efficiency

a. RT-qPCR technology enables test results to be generated within hours, which helps medical institutions make quick decisions during the epidemic of acute respiratory infections.


b. One-stop detection of multiple pathogens

    Greatly saves sample collection and processing time, reduces costs, and is suitable for large-scale testing needs.


International standardization and cross-regional application

a. Unified testing standards 

    The product is designed strictly in accordance with international clinical diagnostic standards to provide technical support for cross-border epidemic monitoring and information sharing.


b. Convenient international promotion 

    The fully premixed freeze-dried system makes the reagents more stable during transportation and storage, meeting the application requirements of different countries and regions.


Support precision medicine and public health prevention and control

a. Assisted differential diagnosis

    It can effectively distinguish SARS-CoV-2 and other common respiratory pathogens, and assist clinicians in formulating more targeted treatment plans.

b. Epidemic monitoring and early warning 

    High-throughput detection capabilities provide real-time data support for CDCs, help achieve early warning and rapid response, and improve the level of public health safety.


Applicable Institutions and Market Prospects

    The Bioteke PR2026-RP06 test kit is mainly for medical laboratories, disease control centers and hospitals, and is suitable for daily diagnosis and epidemic monitoring. 

    With the increasing complexity of respiratory infections around the world, this product not only meets the testing needs of clinical and disease control departments, but also provides reliable technical support for international public health prevention and control and precision medicine, and has broad prospects for international market promotion.


    In the post-epidemic era, respiratory infections are characterized by diverse pathogens and uncertain epidemic patterns. 

    Bioteke PR2026-RP06 respiratory multiple pathogen nucleic acid detection kit has become an important tool in the field of international respiratory infection diagnosis with its advanced RT-qPCR technology and fully premixed freeze-dried system. 


    Choosing Bioteke means choosing an efficient, accurate and convenient detection solution to contribute to global public health prevention and control and precision medicine.


    Get to know Bioteke PR2026-RP06 now and bring a new detection experience to your laboratory and public health prevention and control system!


For further details, please contact Bioteke Team.


Website: www.bioteke.cn

E-mail: zr@bioteke.cn

Phone/Whatsapp: +86 133 5792 7939



YOU MAY LIKE


HPV Genotyping Kit

UTI PCR Panel

STI PCR Kit




Copyright BioTeke Corporation(wuxi) Co.,Ltd  |   苏ICP备18042459号-1